Targeting developmental regulators of zebrafish exocrine pancreas as a therapeutic approach in human pancreatic cancer

Biology Open

Volumn 1, Issue 4, 2012, Pages 295-307

  Yee, Nelson S ^a,b   Zhou, Weiqiang ^b,d   Chun, Stephen G ^b,e   Liang, I Chau ^b,f   Yee, Rosemary K ^c  

^a PENN STATE CANCER INSTITUTE   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c PENNSYLVANIA STATE UNIVERSITY   (United States)

^d SHENYANG MEDICAL COLLEGE   (China)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^f UNIVERSITY OF IOWA   (United States)

Author keywords

Exocrine pancreas; Histone deacetylases; Pancreatic cancer; RNA polymerase III; Suberoylanilide hydroxamic acid; Targeted therapy; Trichostatin A; Zebrafish

Indexed keywords

EID: 84964865993     PISSN: None     EISSN: 20466390     Source Type: Journal    
DOI: 10.1242/bio.2012539     Document Type: Article

References (45)

1. Berrozpe, G., Schaeffer, J., Peinado, M. A., Real, F. X. and Perucho, M. (1994) Comparative analysis of mutations in the p53 and K-ras genes in pancreatic cancer. Int. J. Cancer 58, 185-191.
2. Boyd, D. C., Greger, I. H. and Murphy, S. (2000). In vivo footprinting studies suggest a role for chromatin in transcription of the human 7SK gene. Gene 247, 33-44.
3. Brunmeir, R., Lagger, S. and Seiser, C. (2009). Histone deacetylase 1 and 2-controlled embryonic development and cell differentiation. Int. J. Dev. Biol. 53, 275-289.
4. Cairns, C. A. and White, R. J. (1998). p53 is a general repressor of RNA polymerase III transcription. EMBO J. 17, 3112-3123.
5. Chu, W. M., Wang, Z., Roeder, R. G. and Schmid, C. W. (1997). RNA polymerase III transcription repressed by Rb through its interactions with TFIIIB and TFIIIC2. J. Biol. Chem. 272, 14755-14761.
6. Chun, S. G., Zhou, W. and Yee, N. S. (2009). Combined targeting of histone deacetylases and hedgehog signaling produces enhanced cytotoxicity in pancreatic cancer. Cancer Biol. Ther. 8, 1328-1339.
7. Connell, C. M., Colnaghi, R. and Wheatley, S. P. (2008a). Nuclear survivin has reduced stability and is not cytoprotective. J. Biol. Chem. 283, 3289-3296.
8. Connell, C. M., Wheatley, S. P. and McNeish, I. A. (2008b). Nuclear survivin abrogates multiple cell cycle checkpoints and enhances viral oncolysis. Cancer Res. 68, 7923-7931.
9. Crighton, D., Woiwode, A., Zhang, C., Mandavia, N., Morton, J. P., Warnock, L. J., Milner, J., White, R. J. and Johnson, D. L. (2003). p53 represses RNA polymerase III transcription by targeting TBP and inhibiting promoter occupancy by TFIIIB. EMBO J. 22, 2810-2820.
10. Frew, A. J., Johnstone, R. W. and Bolden, J. E. (2009). Enhancing the apoptotic and therapeutic effects of HDAC inhibitors. Cancer Lett. 280, 125-133.
11. Furukawa, T., Duguid, W. P., Rosenberg, L., Viallet, J., Galloway, D. A. and Tsao, M.-S. (1996). Long-term culture and immortalization of epithelial cells from normal adult human pancreatic ducts transfected by the E6E7 gene of human papilloma virus 16. Am. J. Path. 148, 1763-1770.
12. Haberland, M., Montgomery, R. L. and Olson, E. N. (2009). The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat. Rev. Genet. 10, 32-42.
13. Johnson, S. A., Dubeau, L. and Johnson, D. L. (2008). Enhanced RNA polymerase IIIdependent transcription is required for oncogenic transformation. J. Biol. Chem. 283, 19184-19191.
14. Koorstra, J. B., Hustinx, S. R., Offerhaus, G. J. and Maitra, A. (2008). Pancreatic carcinogenesis. Pancreatology 8, 110-125.
15. Lagger, G., Doetzlhofer, A., Schuettengruber, B., Haidweger, E., Simboeck, E., Tischler, J., Chiocca, S., Suske, G., Rotheneder, H., Wintersberger, E. et al. (2003). The tumor suppressor p53 and histone deacetylase 1 are antagonistic regulators of the cyclin-dependent kinase inhibitor p21/WAF1/CIP1 gene. Mol. Cell. Biol. 23, 2669-2679.
16. Lane, A. A. and Chabner, B. A. (2009). Histone deacetylase inhibitors in cancer therapy. J. Clin. Oncol. 27, 5459-5468.
17. Larminie, C. G., Cairns, C. A., Mital, R., Martin, K., Kouzarides, T., Jackson, S. P. and White, R. J. (1997). Mechanistic analysis of RNA polymerase III regulation by the retinoblastoma protein. EMBO J. 16, 2061-2071.
18. Lee, D. Y., Hayes, J. J., Pruss, D. and Wolffe, A. P. (1993). A positive role for histone acetylation in transcription factor access to nucleosomal DNA. Cell 72, 73-84.
19. Marks, P., Rifkind, R. A., Richon, V. M., Breslow, R., Miller, T. and Kelly, W. K. (2001). Histone deacetylases and cancer: Causes and therapies. Nat. Rev. Cancer 1, 194-202.
20. Marshall, L. and White, R. J. (2008). Non-coding RNA production by RNA polymerase III is implicated in cancer. Nat. Rev. Cancer 8, 911-914.
21. Marshall, L., Kenneth, N. S. and White, R. J. (2008). Elevated tRNA(iMet) synthesis can drive cell proliferation and oncogenic transformation. Cell 133, 78-89.
22. Mei, Y., Yong, J., Liu, H., Shi, Y., Meinkoth, J., Dreyfuss, G. and Yang, X. (2010). tRNA binds to cytochrome c and inhibits caspase activation. Mol. Cell 37, 668-678.
23. Moore, P. S., Sipos, B., Orlandini, S., Sorio, C., Real, F. X., Lemoine, N. R., Gress, T., Bassi, C., Kloppel, G., Kalthoff, H. et al. (2001). Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4. Virchows Arch. 439, 798-802.
24. Noel, E. S., Casal-Sueiro, A., Busch-Nentwich, E., Verkade, H., Dong, P. D. S., Stemple, D. L. and Ober, E. A. (2008). Organ-specific requirements for Hdac1 in liver and pancreas formation. Dev. Biol. 322, 237-250.
25. Noma, K., Cam, H. P., Maraia, R. J. and Grewal, S. I. (2006). A role of TFIIIC transcription factor complex in genome organization. Cell 125, 859-872.
26. Rayman, J. B., Takahashi, Y., Indjejian, V. B., Dannenberg, J. H., Catchpole, S., Watson, R. J., te Riele, H. and Dynlacht, B. D. (2002). E2F mediates cell cycledependent transcriptional repression in vivo by recruitment of an HDAC1/mSin3B corepressor complex. Genes Dev. 16, 933-947.
27. Robertson, K. D., Ait-Si-Ali, S., Yokochi, T., Wade, P. A., Jones, P. L. and Wolffe, A. P. (2000) DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters. Nat. Genet. 25, 338-342.
28. Scott, P. H., Cairns, C. A., Sutliffe, J. E., Alzuherri, H. M., McLees, A., Winter, A. G. and White, R. J. (2001). Regulation of RNA polymerase III transcription during cell cycle entry. J. Biol. Chem. 276, 1005-1014.
29. Siegel, R., Ward, E., Brawley, O. and Jemal, A. (2011). Cancer Statistics, 2011. CA Cancer J. Clin. 61, 212-236.
30. Sutcliffe, J. E., Cairns, C. A., McLees, A., Allison, S. J., Tosh, K. and White, R. J. (1999). RNA polymerase III transcription factor IIIB is a target for repression by pocket proteins p107 and p130. Mol. Cell. Biol. 19, 4255-4261.
31. Westerfield, M. (2007). The Zebrafish Book: A Guide For The Laboratory Use Of Zebrafish (Danio rerio), 5th edn. Eugene, Oregon: University of Oregon Press.
32. White, R. J. (2008). RNA polymerases I and III, non-coding RNAs and cancer. Trends Genet. 24, 622-629.
33. White, R. J., Gottlieb, T. M., Downes, C. S. and Jackson, S. P. (1995). Cell cycle regulation of RNA polymerase III transcription. Mol. Cell. Biol. 15, 6653-6662.
34. White, R. J., Trouche, D., Martin, K., Jackson, S. P. and Kouzarides, T. (1996). Repression of RNA polymerase III transcription by the retinoblastoma protein. Nature 382, 88-90.
35. Wu, L., Pan, J., Thoroddsen, V., Wysong, D. R., Blackman, R. K., Bulawa, C. E., Gould, A. E., Ocain, T. D., Dick, L. R., Errada, P. et al. (2003). Novel smallmolecule inhibitors of RNA polymerase III. Eukaryot. Cell 2, 256-264.
36. Yee, N. S. (2010). Zebrafish as a biological system for identifying and evaluating therapeutic targets and compounds. In Drug Discovery In Pancreatic Cancer (H. Han and P. J. Grippo), 95-112. New York: Springer.
37. Yee, N. S. and Pack, M. (2005). Zebrafish as a model for pancreatic cancer research. Meth. Mol. Med. 103, 273-298.
38. Yee, N. S., Yusuff, S. and Pack, M. (2001). Zebrafish pdx1 morphant displays defects in pancreas development and digestive organ chirality, and potentially identifies a multipotent pancreas progenitor cell. Genesis 30, 137-140.
39. Yee, N. S., Lorent, K. and Pack, M. (2005). Exocrine pancreas development in zebrafish. Dev. Biol. 284, 84-101.
40. Yee, N. S., Gong, W., Huang, Y., Lorent, K., Dolan, A. C., Maraia, R. J. and Pack, M. (2007). Mutation of RNA pol III subunit rpc2/polr3b leads to deficiency of subunit Rpc11 and disrupts zebrafish digestive development. PLoS Biol. 5, 2484-2492.
41. Yee, N. S., Zhou, W. and Lee, M. (2010). Transient receptor potential channel TRPM8 is over-expressed and required for cellular proliferation in pancreatic adenocarcinoma. Cancer Lett. 297, 49-55.
42. 2+-sensitive Socs3a signaling in development and cancer. Dis. Model Mech. 4, 240-254.
43. Yoshida, M., Kijima, M., Akita, M. and Beppu, T. (1995). Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by Trichostatin A. J. Biol. Chem. 265, 17174-17179.
44. Zhou, W., Liang, I.-C. and Yee, N. S. (2011) Histone deacetylase 1 is required for exocrine pancreatic epithelial proliferation in development and cancer. Cancer Biol. Ther. 11, 659-670.
45. Zupkovitz, G., Tischler, J., Posch, M., Sadzak, I., Ramsauer, K., Egger, G., Grausenburger, R., Schweifer, N., Chiocca, S., Decker, T. et al. (2006) Negative and positive regulation of gene expression by mouse histone deacetylase 1. Mol. Cell. Biol. 26, 7913-7928.